Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.

Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.

We describe the interrater variability in the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. Two physicians blinded to their previous assessments and to each other's scores consecutively examined 168 patients (545 paired examinations)...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Noseworthy, J, Vandervoort, M, Wong, C, Ebers, G
Format:	Journal article
Język:	English
Wydane:	1990

Podobne zapisy

INTERRATER VARIABILITY WITH THE EXPANDED DISABILITY STATUS SCALE (EDSS) AND FUNCTIONAL-SYSTEMS (FS) IN A MULTIPLE-SCLEROSIS CLINICAL-TRIAL
od: Noseworthy, J, i wsp.
Wydane: (1990)

EDSS RELIABILITY - REPLY
od: Noseworthy, J, i wsp.
Wydane: (1991)

Expanded Disability Status Scale (EDSS) in Multiple Sclerosis
od: Serkan Demir
Wydane: (2022-12-01)

Acceptance of placebo-control trial design by progressive multiple sclerosis patients. The Canadian Cooperative Multiple Sclerosis Study Group.
od: Noseworthy, J, i wsp.
Wydane: (1989)

Surrogate endpoints for EDSS worsening in multiple sclerosis: a meta-analytic approach: measuring disability in relapsing-remitting MS.
od: Ebers, G, i wsp.
Wydane: (2011)

Disability status and quality of life in multiple sclerosis: non-linearity of the Expanded Disability Status Scale (EDSS)
od: Pöhlau Dieter, i wsp.
Wydane: (2010-06-01)

Effect of Vitamin D supplements on relapse rate and Expanded Disability Status Scale (EDSS) in multiple sclerosis (MS): A systematic review and meta-analysis
od: Sara Hanaei, i wsp.
Wydane: (2021-01-01)

Plasma exchange for MS.
od: Noseworthy, J, i wsp.
Wydane: (1990)

PLASMA-EXCHANGE FOR MS
od: Noseworthy, J, i wsp.
Wydane: (1990)

The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. The Canadian Cooperative Multiple Sclerosis Study Group.
od: Noseworthy, J
Wydane: (1991)

The assessment of the patients disability degree using the EDSS scale in various forms of multiple sclerosis
od: Magda Kucharczuk, i wsp.
Wydane: (2018-03-01)

The assessment of the patients disability degree using the EDSS scale in various forms of multiple sclerosis
od: Magda Kucharczuk, i wsp.
Wydane: (2018-03-01)

MS REFERENDUM - REPLY
od: Noseworthy, J, i wsp.
Wydane: (1990)

Erratum: Plasma exchange for MS (Neurology (1990) 40 (864-866))
od: Noseworthy, J, i wsp.
Wydane: (1990)

Physical disability assessment: EDSS calculation (ORP-05)
od: Zahra Ebadi
Wydane: (2023-11-01)

ACCEPTANCE OF PLACEBO-CONTROL TRIAL DESIGN BY PROGRESSIVE MULTIPLE-SCLEROSIS PATIENTS
od: Noseworthy, J, i wsp.
Wydane: (1989)

Measuring disability progression in MS
od: Ebers, G, i wsp.
Wydane: (2005)

The Effect of Walking Distance on EDSS Score in Patients with Multiple Sclerosis
od: Kadriye Balcı Tombak, i wsp.
Wydane: (2010-06-01)

The Effect of Walking Distance on EDSS Score in Patients with Multiple Sclerosis
od: Kadriye Balcı Tombak, i wsp.
Wydane: (2010-06-01)

Health-related quality of life in multiple sclerosis: temperament outweighs EDSS
od: S. Salhofer-Polanyi, i wsp.
Wydane: (2018-05-01)

A referendum on clinical trial research in multiple sclerosis: the opinion of the participants at the Jekyll Island workshop.
od: Noseworthy, J, i wsp.
Wydane: (1989)

Disability as an outcome in MS clinical trials.
od: Ebers, G, i wsp.
Wydane: (2008)

MULTIPLE-SCLEROSIS (MS) PRESENTING IN PATIENTS OVER 50 YEARS OF AGE
od: Noseworthy, J, i wsp.
Wydane: (1981)

The Mayo Clinic-Canadian Cooperative trial of sulfasalazine in active multiple sclerosis.
od: Noseworthy, J, i wsp.
Wydane: (1998)

Inter-rater variability on multiple sclerosis disability scales in a blinded, prospective clinical trial
od: Noseworthy, J, i wsp.
Wydane: (1989)

Is EDSS Enough to Predict Risk of Upper Urinary Tract Damage in Patients with Multiple Sclerosis?
od: Kevin Stritt, i wsp.
Wydane: (2022-11-01)

Effect of 12-Week Pilates Trainning on EDSS in Women Suffering fromMultiple Sclerosis
od: Z Shanazari, i wsp.
Wydane: (2013-04-01)

The Therapeutic Effect of Avonex, Rebif and Betaferon on EDSS and Relapse in Multiple Sclerosis: A Comparative Study
od: Mehrdokht Mazdeh, i wsp.
Wydane: (2010-04-01)

The Therapeutic Effect of Avonex, Rebif and Betaferon on EDSS and Relapse in Multiple Sclerosis: A Comparative Study
od: Mehrdokht Mazdeh, i wsp.
Wydane: (2010-03-01)

The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial.
od: Noseworthy, J, i wsp.
Wydane: (1994)

Utilizing Aerobic Capacity Data for EDSS Score Estimation in Multiple Sclerosis: A Machine Learning Approach
od: Seda Arslan Tuncer, i wsp.
Wydane: (2024-06-01)

The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. 1994 [classical article]
od: Noseworthy, J, i wsp.
Wydane: (2001)

Interrater reliability estimators tested against true interrater reliabilities
od: Xinshu Zhao, i wsp.
Wydane: (2022-08-01)

SJOGRENS-SYNDROME MIMICKING MULTIPLE-SCLEROSIS - REPLY
od: Noseworthy, J, i wsp.
Wydane: (1990)

Diagnoses and Treatment Recommendations—Interrater Reliability of Uroflowmetry in People with Multiple Sclerosis
od: Anke K. Jaekel, i wsp.
Wydane: (2024-07-01)

Cyclophosphamide and MS.
od: Noseworthy, J, i wsp.
Wydane: (1994)

CYCLOPHOSPHAMIDE AND MS
od: Noseworthy, J, i wsp.
Wydane: (1994)

Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis.
od: Wiebe, S, i wsp.
Wydane: (1992)

Serum Neurofilaments and OCT Metrics Predict EDSS-Plus Score Progression in Early Relapse-Remitting Multiple Sclerosis
od: Vlad Eugen Tiu, i wsp.
Wydane: (2023-02-01)

Primary biliary cirrhosis and multiple sclerosis.
od: Noseworthy, J, i wsp.
Wydane: (1989)